Drawing for CENIX BIOSCIENCE

USPTO serial 76470765

CENIX BIOSCIENCE

Reviewed by CopyMark Law Group

Reg. 3014405Status 710
Filing date
Status date
Registration date
Nov 15, 2005
Examiner
KAZAZIAN, MICHAEL H
Law office
TMO LAW OFFICE 113

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CENIX BIOSCIENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Theodore D. Lienesch

Theodore D. Lienesch THOMPSON HINE LLP10050 Innovation Drive, Suite 400DAYTON, OH 45342-4934UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009downloadable computer databases and computer databases recorded on computer media in the fields of biotechnology, bioscience, genomics, therapeutics and pharmacology, including gene-specific characteristicsSECTION 8 - CANCELLED—
038providing multiple user access to databases in the fields of biotechnology, bioscience, genomics, therapeutics and pharmacology, including gene-specific phenotype characteristics, on a global computer information networkSECTION 8 - CANCELLED—
042scientific, medical and pharmaceutical research and development, namely, the identification, validation and characterization of drug target genes, molecules and biochemical pathways, analysis of gene functions, drug development programs for conventional and RNAi-based therapeutics, screening for pharmacological and biochemical compounds; consulting services in the field of scientific, medical and pharmaceutical research and development; developing and maintaining databases of information for others in the fields of biotechnology, bioscience, genomics, therapeutics, and pharmacology, including gene-specific phenotype characteristics; information services, namely, online databases provided through global communications networks [ and local computer networks ] featuring technological information and scientific and medical research information in the fields of biotechnology, bioscience, genomics, therapeutics and pharmacologySECTION 8 - CANCELLED—
044information services, namely, online databases provided through global communications networks [, and local computer networks ] featuring medical information in the fields of biotechnology, bioscience, genomics, therapeutics and pharmacologySECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 17, 2016CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
May 31, 2012NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
May 31, 2012C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
May 24, 2012APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 15, 2012E815TEAS SECTION 8 & 15 RECEIVED—
Nov 15, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 20, 2005DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jun 15, 2005IUCNNOTICE OF ALLOWANCE CANCELLED—
Jun 15, 2005D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Jun 9, 2005COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 24, 2005PC.DPETITION TO DIRECTOR DISMISSED—
Dec 21, 2004EX1GSOU EXTENSION 1 GRANTED—
Dec 10, 2004EXT1SOU EXTENSION 1 FILED—
Dec 10, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 27, 2004PCRCPETITION TO DIRECTOR RECEIVED—
Sep 27, 2004MAILPAPER RECEIVED—
Jun 15, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 23, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 3, 2004NPUBNOTICE OF PUBLICATION—
Jan 22, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 22, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 22, 2003MAILPAPER RECEIVED—
Jun 24, 2003GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2003DOCKASSIGNED TO EXAMINER—
May 22, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 10, 200344DASEC. 44(D) CLAIM ADDED—

Frequently asked questions

Related guidance